Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 796,621 $ 573,698
Premium and related receivables 316,123 157,450
Short-term investments 139,920 130,499
Other current assets 123,841 78,363
Total current assets 1,376,505 940,010
Long-term investments 559,714 506,140
Restricted deposits 33,509 26,818
Property, software and equipment, net 381,781 349,622
Goodwill 256,288 281,981
Intangible assets, net 21,375 27,430
Other long-term assets 61,764 58,335
Total assets 2,690,936 2,190,336
Current liabilities:    
Medical claims liability 919,032 607,985
Premium deficiency reserve 63,000 0
Accounts payable and accrued expenses 162,778 216,504
Unearned revenue 131,967 9,890
Current portion of long-term debt 3,337 3,234
Total current liabilities 1,280,114 837,613
Long-term debt 391,973 348,344
Other long-term liabilities 61,785 67,960
Total liabilities 1,733,872 1,253,917
Commitments and contingencies      
Stockholders' equity:    
Common stock, $.001 par value; authorized 100,000,000 shares; 54,405,296 issued and 51,632,704 outstanding at September 30, 2012, and 53,586,726 issued and 50,864,618 outstanding at December 31, 2011 54 54
Additional paid-in capital 458,741 421,981
Accumulated other comprehensive income:    
Unrealized gain on investments, net of tax 6,702 5,761
Retained earnings 557,759 564,961
Treasury stock, at cost (2,772,592 and 2,722,108 shares, respectively) (59,277) (57,123)
Total Centene stockholders' equity 963,979 935,634
Noncontrolling interest (6,915) 785
Total stockholders' equity 957,064 936,419
Total liabilities and stockholders' equity $ 2,690,936 $ 2,190,336